Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Stranded dolphins' brains show classic markers of Alzheimer's disease
“These are significant findings that show, for the first time, that the brain pathology in stranded odontocetes is similar to the brains of humans affected by clinical Alzheimer’s disease" - Dr Mark Dagleish, University of Glasgow.
The finding could explain the underlying cause of live-stranding events.

Researchers in Scotland have discovered that the brains of stranded dolphins show the classic markers of Alzheimer's disease in humans.

The study, published in the European Journal of Neuroscience, was conducted by the University of Glasgow in collaboration with the Universities of St Andrews and Edinburgh and the Moredon Research Institute.

Scientists believe their results could explain the underlying cause of live-stranding events that are not always clear. They also confirm the 'sick leader' hypothesis, by which an otherwise healthy animal pod finds itself in dangerously shallow waters following the loss of a group leader that may have become confused.

In the study, researchers analysed the brains of 22 odontocetes that had been stranded in the coastal waters of Scotland, including Risso’s dolphins, long-finned pilot whales, white-beaked dolphins, harbour porpoises and bottlenose dolphins. Four of the five dolphin species showed some brain alterations associated with human Alzheimer's disease. 

In particular, three species had amyloid-beta plaques and several other dementia-related pathologies in their brains, suggesting that some odontocete species develop Alzheimer’s-like neuropathology. However, the authors stress their findings cannot confirm whether the animals would have suffered from the same cognitive deficits associated with clinical Alzheimer’s disease in humans. 

Dr Mark Dagleish from the University of Glasgow and lead researcher, said: “These are significant findings that show, for the first time, that the brain pathology in stranded odontocetes is similar to the brains of humans affected by clinical Alzheimer’s disease. 

“While it is tempting at this stage to speculate that the presence of these brain lesions in odontocetes indicates that they may also suffer with the cognitive deficits associated with human Alzheimer’s disease, more research must be done to better understand what is happening to these animals".

Professor Tara Spires-Jones, University of Edinburgh, said: “We were fascinated to see brain changes in aged dolphins similar to those in human ageing and Alzheimer’s disease. Whether these pathological changes contribute to these animals' stranding is an interesting and important question for future work”.

Become a member or log in to add this story to your CPD history

First BTV-3 case of 2026/27 season confirmed

News Story 1
 Livestock keepers are being urged to stay vigilant for Bluetongue (BTV-3) following confirmation of the disease in a ewe. The case, confirmed in Staffordshire on 23 June 2026, represents the first confirmed case of infection this summer.

The APHA said: 'The risk of Bluetongue spreading has increased so we urge all livestock keepers in GB to familiarise themselves with the nation specific bluetongue control policies and movement requirements that currently apply.'  

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.